Venn Life Sciences Holdings (VENN)

 

VENN Share PerformanceMore

52 week high30.300 03/08/16
52 week low16.580 27/02/17
52 week change -3.000 (-15.19%)
4 week volume1,297,460 01/02/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Venn Life Sciences completes Innovenn UK stake sale

Venn Life Sciences has completed the sale of its shareholding in Innovenn UK Ltd to Integumen Ltd and notes that compa...

Completion of Sale

RNS Number: 5204P Venn Life Sciences Holdings PLC 18 November 2016 Venn Life Sciences Holdings Plc ("Venn" or the "Company") Completion of Sale Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical devic...

REPLACEMENT - Contract win

RNS Number: 9217O Venn Life Sciences Holdings PLC 10 November 2016 The following amendment(s) have been made to the Venn Life Sciences Holdings plc - Contract Win announcement released on 8 November 2016 at 07:00 under RNS No 5443O. The correction relates to notification that the contract win is a related party transaction under the AIM Rules and E...

Venn Life Sciences confirms contract win

Venn Life Sciences has signed a new contract worth 2.5m with Sedana Medical AB. Venn will carry out a randomised, con...

Contract win

RNS Number: 5443O Venn Life Sciences Holdings PLC 08 November 2016 Venn Life Sciences Holdings Plc ("Venn Life Sciences" or the "Company") Contract win Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medic...

Director Deals - Venn Life Sciences Holdings PLC (VENN)

Allan Wood, Chairman, bought 230,000 shares in the company on the 31st October 2016 at a price of 21.67p. The Director no...

Director/PDMR Shareholding

RNS Number: 0838O Venn Life Sciences Holdings PLC 02 November 2016 Venn Life Sciences Holdings Plc ("Venn Life Sciences" or the "Company") Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 1 Details of the person discharging managerial responsibilities / person close...

Sale of Innovenn UK Limited and Result of GM

RNS Number: 5674N Venn Life Sciences Holdings PLC 27 October 2016 Venn Life Sciences Holdings Plc ("Venn Life Sciences" or the "Company") Sale of Innovenn UK Limited and Result of General Meeting Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation providing drug development, clinical trial management and resourcing solution...

Equity Research (VENN)

Venn Life Sciences Holdings plc
08/11/2016
The growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, has...
Venn Life Sciences Holdings plc
13/09/2016
Venn Life Sciences* (VENN.L) 28p £16.9m The growing Clinical Research Organisation providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device...
Venn Life Sciences Holdings plc
03/08/2016
The growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, has...

Latest discussion posts More

  • RNS : Integumen IPO on track

    Great to see the sale of Innovenn proceeding smoothly and now completed per today's ...
    18-Nov-2016
    gretel
  • RNS re new 2.5m euro contract win

    Great news - and since it starts immediately it will contribute to this year's results too, so the 2016 numbers should be extremely impressive given what we know. From now ...
    8-Nov-2016
    gretel
  • Exciting spin-off news today

    VENN will initially own 70% of a Newco (Integumen) which is to be set up as a consolidator of healthcare technologies, by converting its loan to Innovenn into shares in ...
    4-Oct-2016
    gretel

Users' HoldingsMore

Users who hold Venn Life Sciences Holdings also hold..
APC TECHNOLOGY35%
DIGITAL BARRIER21%
VODAFONE GRP.21%
TULLOW OIL14%
ROYAL BANK SCOT14%

Codes & Symbols

ISINGB00B9275X97
SymbolsVENN, LSE:VENN, VENN.L, VENN:LN, LON:VENN, XLON:VENN